Helix has since shut down its app store and stopped selling genome sequencing directly to consumers.
Notes on verification
Corroborated by multiple independent trade press sources (GenomeWeb, FierceBiotech, Becker's), industry analysts (CB Insights, Crunchbase), and a competitor review site, all consistent on timeline and pivot to B2B/population genomics. [tier=bronze indep_score=0.525 clusters=5 claim_tier=notable | kind=empirical eligibility=high]
Sources
- Why some 'breakthrough' technologies don't work out (seed:technology_and_ai)
- https://sequencing.com/blog/post/dna-app-store (corroboration)
- https://www.fiercebiotech.com/medtech/dna-sequencing-test-maker-helix-doubles-down-covid-19-testing-tracking-50m-series-c (corroboration)
- https://www.cbinsights.com/research/helix-genomics-business-model/ (corroboration)
- https://www.genomeweb.com/business-news/helix-reduces-workforce-closes-offices-amid-strategic-shift (corroboration)
- https://nebula.org/blog/helix-dna-review/ (corroboration)
- https://www.cbinsights.com/company/helix (corroboration)